Duygu Kuzuoglu Ozturk
Assistant Prof
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (10)
Selective inhibition of mRNA translation is a promising strategy for modulating the activity of disease-associated genes, yet achieving both high potency and specificity remains challenging. Rocaglamide A (RocA), a molecular glue, inhibits translation by clamping eIF4A onto polypurine motifs found in many transcripts, thereby limiting RocA’s specificity. Here, we developed RocASO, a chemical conjugate that links RocA to an antisense oligonucleotide (ASO) capable of base-pairing with defined mRNA sequences, thus directing RocA’s clamping mechanism to chosen targets and enhancing overall potency and specificity. We show that RocASOs are compatible with various types of ASO modalities, including gapmers that induce the degradation of target RNAs. RocASOs were designed to effectively knock down endogenous genes ( PTGES3 , HSPA1B ) and SARS-CoV-2 viral RNA, the latter conferring potent antiviral activity in cells. These findings establish RocASO as a versatile platform for programmable translational inhibition with therapeutic potential.
Year:
2025
Supplementary Figure 6 shows clinical data analysis of neoadjuvant androgen axis inhibition in primary prostate cancer as well as expression analysis of AR, MHCI, and IFNG activity in mHSPC clinical samples.
Year:
2025
Year:
2025
Supplementary Figure 6 shows clinical data analysis of neoadjuvant androgen axis inhibition in primary prostate cancer as well as expression analysis of AR, MHCI, and IFNG activity in mHSPC clinical samples.
Year:
2025
Year:
2025
Tumors escape immune detection and elimination through a variety of mechanisms. Here, we used prostate cancer as a model to examine how androgen-dependent tumors undergo immune evasion through downregulation of the major histocompatibility complex class I (MHCI). We report that response to immunotherapy in late-stage prostate cancer is associated with elevated MHC expression. To uncover the mechanism, we performed a genome-wide CRISPR interference (CRISPRi) screen and identified androgen receptor ( AR ) as a repressor of the MHCI pathway. Syngeneic mouse models of aggressive prostate cancer deficient in Ar also demonstrated increased tumor immunogenicity and promoted T cell–mediated tumor control. Notably, the increase in MHCI expression upon AR blockade is transient and correlates with resistance to AR inhibition. Mechanistic studies identified androgen response elements upstream of MHCI transcription start sites which increased MHCI expression when deleted. Together, this body of work highlights another mechanism by which hormones can promote immune escape. Significance: Immunotherapy options for immune cold tumors, like prostate cancer, are limited. We show that AR downregulates MHCI expression/antigen presentation and that AR inhibition improves T-cell responses and tumor control. This suggests that treatments combining AR inhibitors and checkpoint blockade may improve tumor immune surveillance and antitumor immunity in patients.
Year:
2025
Deregulation of neuroblastoma-derived myc (N-myc) is a leading cause of malignant brain tumors in children. To target N-myc-driven medulloblastoma, most research has focused on identifying genomic alterations or on the analysis of the medulloblastoma transcriptome. Here, we have broadly characterized the translatome of medulloblastoma and shown that N-myc unexpectedly drives selective translation of transcripts that promote protein homeostasis. Cancer cells are constantly exposed to proteotoxic stress associated with alterations in protein production or folding. It remains poorly understood how cancers cope with proteotoxic stress to promote their growth. Here, our data revealed that N-myc regulates the expression of specific components (∼5%) of the protein folding machinery at the translational level through the major cap binding protein, eukaryotic initiation factor eIF4E. Reducing eIF4E levels in mouse models of medulloblastoma blocked tumorigenesis. Importantly, targeting Hsp70, a protein folding chaperone translationally regulated by N-myc, suppressed tumor growth in mouse and human medulloblastoma xenograft models. These findings reveal a previously hidden molecular program that promotes medulloblastoma formation and identify new therapies that may have impact in the clinic. Significance: Translatome analysis in medulloblastoma shows that N-myc drives selective translation of transcripts that promote protein homeostasis and that represent new therapeutic vulnerabilities.
Year:
2025
Year:
2023
Year:
2023
Year:
2023
Collaborators (26)
Thomas O'Loughlin
Icahn School of Medicine at Mount Sinai
Davide Ruggero
Professor
University of California
Nevan Krogan
Professor
University of California, San Francisco
David A. Quigley
Assistant Professor
University of California, San Francisco
Wilbert Zwart
Senior Groupleader / professor
Eindhoven University of Technology
Robert Wechsler-Reya
Professor
Columbia University Irving Medical Center
Luke Gilbert
Assistant Professor
University of California, San Francisco
Alan Ashworth
University of California, San Francisco
Zheng Xia
Associate Professor
University of Texas at Austin
Adam Sowalsky
Senior Investigator
National Cancer Institute
Michelle Badura
Lecturer
Santa Clara University
Danielle Swaney
University of California, San Francisco
Raunak Shrestha
Assistant Professor
Uniformed Services University of the Health Sciences
Lawrence Fong
Fred Hutch Cancer Center
Matthew R. Cooperberg
University of California
Arian Lundberg
Assistant Professor at KTH Royal Institute of Technology
KTH Royal Institute of Technology
Jason E. Gestwicki
Professor
University of California, San Francisco
Felix Y. Feng
University of California
Melanie Ott
Professor
University of California, San Francisco
Miller Huang
Assistant Professor
University of Southern California
Joanna Kovalski
Assistant Professor
University of North Carolina at Chapel Hill
Joanna J. Phillips
Profesor
University of California, San Francisco
Kevan Shokat
Professor
UCSF Medical Center
Jessica Hawley
Assistant Professor
University of Washington
Maria Barna
Stanford University School of Medicine
William A. Weiss
Director of outpatient child neurology
University of California
Make your next move.
Prepare your application
Review drafts before you send them.